Literature DB >> 24256943

Prerequisite OCT4 Maintenance Potentiates the Neural Induction of Differentiating Human Embryonic Stem Cells and Induced Pluripotent Stem Cells.

Sheng-Mei Chen1, Maw-Sheng Lee, Chia-Yu Chang, Shinn-Zong Lin, En-Hui Cheng, Yung-Hsien Liu, Hong-Chuan Pan, Hsiu-Chin Lee, Hong-Lin Su.   

Abstract

Establishing an efficient differentiation procedure is prerequisite for the cell transplantation of pluripotent stem cells. Activating fibroblast growth factor (FGF) signals and inhibiting the activin/nodal pathway are both conserved principles to direct the neural induction (NI) of developing embryos and human embryonic stem cells (hESCs). Wnt signal and OCT4 expression are critical for the hESC pluripotency; however, their roles in cell differentiation are largely unclear. We demonstrate that in the presence of FGF2 and activin inhibitor SB431542, applying a small-molecule Wnt agonist, BIO, efficiently and rapidly steers the NI of all our tested hESCs. A human induced pluripotent stem cell (iPSC), which is refractory for efficient neural conversion by FGF2, effectively differentiated to SOX1(+) cells after the BIO/SB431542/FGF2 treatment. In addition, BIO promoted cell survival and transiently sustained OCT4 expression at the early NI stage with FGF2 and SB431542. Interestingly, at the late NI stage, the OCT4 level rapidly declined in the treated hESCs and consequently initiated the formation of neural rosettes with forebrain neuron characteristics. This study illustrates the distinct effects of Wnt activation on maintaining pluripotency and committing neural lineages at the early and late NI stages of hESCs and iPSCs, respectively.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24256943     DOI: 10.3727/096368913X675179

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  9 in total

1.  Oct4 dependent chromatin activation is required for chicken primordial germ cell migration.

Authors:  Lu Meng; Sheng Wang; Haoyi Jiang; Yao Hua; Binxu Yin; Xiaochen Huang; Qiu Man; Heng Wang; Guiyu Zhu
Journal:  Stem Cell Rev Rep       Date:  2022-04-09       Impact factor: 6.692

2.  Susceptibility of human embryonic stem cell-derived neural cells to Japanese encephalitis virus infection.

Authors:  Shih-Cheng Shen; Ching-I Shen; Ho Lin; Chun-Jung Chen; Chia-Yu Chang; Sheng-Mei Chen; Hsiu-Chin Lee; Ping-Shan Lai; Hong-Lin Su
Journal:  PLoS One       Date:  2014-12-17       Impact factor: 3.240

3.  N-butylidenephthalide attenuates Alzheimer's disease-like cytopathy in Down syndrome induced pluripotent stem cell-derived neurons.

Authors:  Chia-Yu Chang; Sheng-Mei Chen; Huai-En Lu; Syu-Ming Lai; Ping-Shan Lai; Po-Wen Shen; Pei-Ying Chen; Ching-I Shen; Horng-Jyh Harn; Shinn-Zong Lin; Shiaw-Min Hwang; Hong-Lin Su
Journal:  Sci Rep       Date:  2015-03-04       Impact factor: 4.379

4.  Extracellular Pgk1 enhances neurite outgrowth of motoneurons through Nogo66/NgR-independent targeting of NogoA.

Authors:  Cheng Yung Lin; Chia Lun Wu; Kok Zhi Lee; You Jei Chen; Po Hsiang Zhang; Chia Yu Chang; Horng Jyh Harn; Shinn Zong Lin; Huai Jen Tsai
Journal:  Elife       Date:  2019-07-30       Impact factor: 8.140

Review 5.  CRISPR/Cas system: An emerging technology in stem cell research.

Authors:  Maria Teresa Valenti; Michela Serena; Luca Dalle Carbonare; Donato Zipeto
Journal:  World J Stem Cells       Date:  2019-11-26       Impact factor: 5.326

6.  Differentiation of Human Pluripotent Stem Cells Into Specific Neural Lineages.

Authors:  Chia-Yu Chang; Hsiao-Chien Ting; Ching-Ann Liu; Hong-Lin Su; Tzyy-Wen Chiou; Horng-Jyh Harn; Shinn-Zong Lin; Tsung-Jung Ho
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

Review 7.  Induced pluripotent stem cells in Alzheimer's disease: applications for disease modeling and cell-replacement therapy.

Authors:  Juan Yang; Song Li; Xi-Biao He; Cheng Cheng; Weidong Le
Journal:  Mol Neurodegener       Date:  2016-05-17       Impact factor: 14.195

8.  Induced Pluripotent Stem Cells: A Powerful Neurodegenerative Disease Modeling Tool for Mechanism Study and Drug Discovery.

Authors:  Chia-Yu Chang; Hsiao-Chien Ting; Ching-Ann Liu; Hong-Lin Su; Tzyy-Wen Chiou; Horng-Jyh Harn; Shinn-Zong Lin
Journal:  Cell Transplant       Date:  2018-06-12       Impact factor: 4.064

9.  SOX2 for Stem Cell Therapy and Medical Use: Pros or Cons?

Authors:  Hong-Meng Chuang; Mao-Hsuan Huang; Yu-Shuan Chen; Horng-Jyh Harn
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.